Miller S D, Claman H N
J Immunol. 1976 Nov;117(5 Pt 1):1519-26.
BALB/c mice were made tolerant to the T cell-dependent phenomenon of contact sensitivity to DNFB by i.v. injection of syngeneic lymphoid cells which had been previously modified with DNFB in vitro. The highly efficient unresponsiveness, as measured by ear challenge and in vitro antigen-induced cell proliferation, was shown to follow dose-response kinetics both in vivo and in vitro and to be exquisitely specific for the DNP moiety. The kinetics of tolerance induction were shown to be very rapid and had been previously shown to be long lasting. Unresponsiveness was more efficient when the hapten-modified cells were introduced by the i.v. route and tolerance could be increased by repeated injection of tolerogen. The tolerance could be transferred to normal syngeneic recipients by spleen and/or lymph node cells from tolerant donors. A wide variety of hapten-modified lymphoid cells, including mixed cell populations and enriched populations of T cells, B cells, and macrophages, were capable of inducing tolerance. The unresponsiveness was dependent merely on the association of DNP to the lymphoid membrane proteins and not upon the viability of the hapten-modified cells. These experiments support the hypothesis that in hapten-specific T cell sensitivity, as exemplified by contact sensitivity to DNFB, specific T cell tolerance in actively induced by hapten on self-membrane. In other hapten-specific antibody-forming systems, tolerance appears to be most readily induced by hapten on soluble self protein or on a nonimmunogeneic carrier.
通过静脉注射经二硝基氟苯(DNFB)体外修饰的同基因淋巴细胞,使BALB/c小鼠对DNFB接触敏感性这种T细胞依赖性现象产生耐受。通过耳部激发试验和体外抗原诱导的细胞增殖测定,这种高效的无反应性在体内和体外均呈现剂量反应动力学,并且对二硝基苯基(DNP)部分具有高度特异性。耐受诱导的动力学显示非常迅速,并且先前已证明其具有持久性。当通过静脉途径引入半抗原修饰的细胞时,无反应性更有效,并且通过重复注射耐受原可增强耐受性。耐受性可通过耐受供体的脾脏和/或淋巴结细胞转移至正常同基因受体。多种半抗原修饰的淋巴细胞,包括混合细胞群体以及T细胞、B细胞和巨噬细胞的富集群体,都能够诱导耐受。无反应性仅取决于DNP与淋巴细胞膜蛋白的结合,而不取决于半抗原修饰细胞的活力。这些实验支持了这样的假说:在半抗原特异性T细胞敏感性中,如对DNFB的接触敏感性所示,自身膜上的半抗原可主动诱导特异性T细胞耐受。在其他半抗原特异性抗体形成系统中,耐受性似乎最容易由可溶性自身蛋白或非免疫原性载体上的半抗原诱导产生。